| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.05 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |